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ABSTRACT: Organic and printed electronics integration has the potential to revolutionise many technologies, including biomedical 
diagnostics. This work demonstrates the successful integration of multiple printed electronic functionalities into a single device ca-
pable of the measurement of hydrogen peroxide, and total cholesterol. The single-use device employed printed electrochemical sen-
sors for hydrogen peroxide electroreduction integrated with printed electrochromic display and battery. The system was driven by a 
conventional electronic circuit designed to illustrate the complete integration of silicon ICs via pick and place, or using organic 
electronic circuits. The device was capable of measuring 8 µL samples of both hydrogen peroxide (0 to 5 mM, 2.72×10-6 A.mM-1) 
and total cholesterol in serum from 0 to 9 mM (1.34×10-8 A.mM-1, r2=0.99, RSD <10%, n=3) which was output on a semi-quantitative 
linear bar display. The device could operate for 10 minutes via a printed battery and display the result for many hours or days. A 
mobile phone ‘app’ was also capable of reading the test result and transmitting this to a remote health care provider. Such a technology 
could allow improved management of conditions such as hypercholesterolemia. 
Printed electronics is being hailed as a technological revolu-
tion, equal in importance to the emergence of microelectronics 
over 50 years ago. The combined qualities of print-processable 
organic, inorganic and hybrid (semi)conductive materials 
which can be deposited onto flexible polymeric substrates using 
a range of additive, high throughput printing methodologies of-
fer the prospect of low cost  mass production capability and the 
potential for unprecedented levels of technological integra-
tion.1-3 This potent combination is transformational in the ways 
in which we use electronic technologies, and further embed 
them into our daily lives. Such technologies are already being 
integrated into many everyday appliances such as organic light 
emitting diode (OLED) displays on TVs, tablets and phones, 
integrated lighting on product packaging, vehicles and in the 
built environment, printed RFID tags for object tracking and 
many more besides.1, 4, 5 
One area that has great potential for its integration with or-
ganic and printed electronics is that of sensors and diagnostics. 
In fact, sensors – electrochemical sensors at least – could be 
regarded as far ahead of their time in the development of printed 
electronics. Printed electrochemical sensor strips have been 
with us for some 20 years now for application in blood glucose 
monitoring and have featured the use of conductive inks printed 
onto planar substrates to form printed electrodes as the basis of 
miniaturized electrochemical cells.6,7 Other reagents such as en-
zymes and mediators have also been effectively integrated and 
deposited using screen printing techniques. However, to per-
form the rest of the measurement, the printed sensor has always 
been dependent on a number of traditional elements which in-
clude displays, batteries and silicon circuitry external to the sen-
sor in the form of a meter. In addition, the cost and complexity 
of the meter components dictates that they are used repeatedly 
and require maintenance and calibration.  
The next stage of technological evolution is to fully integrate 
all of these components into a single monolithic device through 
the medium of organic and printed electronics. However, to 
achieve this, several technological hurdles have to be overcome. 
Most of these relate to the types and range of materials that must 
be amenable to integrated fabrication processing methods. This 
means having the appropriate functionality, print processability 
and compatibility with other materials and other processes used 
during manufacturing. This results in a significant complexity 
challenge to effectively combine all these functionalities into 
operational devices. 
In this work, we demonstrate the fabrication and integration of 
printed electrochemical sensors, electrochromic display and 
battery onto a single polymeric substrate. The integrated sensor 
system (SIMS) combines various organic, flexible and printed 
electronics (OFPE) technologies with potential for application 
in diagnostics and other areas. In addition, we demonstrate its 
interfacing with simplified conventional electronic circuits as a 
prelude for future full integration of pick and place silicon chips 
or organic electronic circuits.
  
Figure 1. Complete layer stack of the SIMS device. A printed card device cover with display window, QR code, printed cholesterol level 
and color coding. Transparent polymer substrate layer based on polyethylene naphthalate foil for high dimensional stability during pro-
cessing. Common silver layer for interconnects for sensor, display and battery. Display, battery and sensor layer stacks are shown in detail 
in Figs. 2, 3 and 5. 
EXPERIMENTAL SECTION 
Devices were fabricated on polyethylene napthalate (PEN) sub-
strates of 100 mm × 80 mm (Teonex Q65FA) (Teijin Dupont 
Films), modified with indium-doped tin oxide (ITO). Q65FA 
was chosen for its excellent characteristics of process compati-
bility and dimensional stability. The ITO display current collec-
tor was patterned by etching. Silver tracks were deposited using 
screen printing of Electrodag PF-410 (Henkel) on a DEK 248 
screen printer (DEK, UK). All display components were depos-
ited using screen printing of the electrochromic ink set (Na-
noChromics™ Print Trial Kit TKG-3.1) developed by NTera 
(Dublin, Ireland). Dual three electrode electrochemical cells 
were fabricated using screen printing. Silver (PF-410) was used 
as the conductor and working electrodes, while Ag/AgCl Elec-
trodag 6037 SS and carbon Electrodag 6017 SS (Henkel) were 
used as reference and common counter electrodes, respectively. 
Working electrode area was 3 mm × 3 mm. 
Batteries were fabricated using a combination of screen print-
ing, gluing and lamination. The current collectors were fabri-
cated using screen printing of PF-407C (Henkel). Anodes and 
cathodes employed manganese dioxide and zinc-based inks, re-
spectively. The anode and cathode were laminated together em-
ploying double-sided glue tape with polymer separator layer 
and ZnCl2 gel electrolyte. 
For the demonstration of the measurement of H2O2, elec-
trodes were modified with the inkjet-printed deposition of Tri-
ton X-100 (0.25% v/v) in PBS as electrocatalyst using a Di-
matix DMP 2831 inkjet printer, with an estimated total volume 
of 952 nL. For the measurement of TC, four inkjet-printed lay-
ers of cholesterol esterase (ChEs) (1.04 kU/mL) and cholesterol 
oxidase (ChOx) (0.39 kU/mL) in 0.25% (v/v) Triton X-100, and 
stabilisers 0.2% (w/v) polyvinylpyrrolidone and poly(dial-
lyldimethylammonium chloride) in PBS were deposited to a to-
tal volume of 1.5 mL and allowed to dry under ambient condi-
tions. Cholesteryl acetate stock solution (500 mg/dL) was pre-
pared in PBS/10% (v/v) Triton X-100. Delipidated serum was 
spiked with cholesteryl acetate stock to achieve concentrations 
of 0.5, 1, 3, 5, 7 and 9 mM total cholesterol (TC). 
For method development, sensors were operated at -100 mV 
vs Ag/AgCl pseudo-reference electrode using an Autolab 
PGSTAT128N with NOVA 1.6 software (Metrohm, UK) in 
time-based amperometric mode. Measurement involved an in-
cubation period of 200 s, followed by amperometric measure-
ment for 240 s. The concentration of cholesteryl acetate was 
correlated against the current at 240 s. For operation of the 
SIMS device, incubation and amperometric measurement were 
combined into a single interval of 400 s. 
RESULTS AND DISCUSSION 
Fig. 1 illustrates the complete twenty-two layer stack of the 
SIMS device. The development of the integrated sensor system 
involved the combination of multiple heterogeneous fabrication 
processes and associated materials including screen printing of 
metallic and non-metallic conductors, inkjet printing of func-
tional electrocatalysts, enzymes and stabilizers, photolithogra-
phy and lamination, to combine printed sensor, display and bat-
tery onto a single polyethylene naphthalate (PEN) substrate. 
The following sections detail the individual component charac-
teristics and the operation of the integrated device in the meas-
urement of H2O2 and total cholesterol (TC). 
Printed electrochromic display. The display is a critical com-
ponent of any diagnostic device as it represents the interface 
between the device and the user and must give clear and unam-
biguous information. Several types of printed display technolo-
gies have been developed including organic light emitting di-
odes (OLEDs), electroluminescence (EL) and electrochromics 
(EC).8,9 While OLEDs offer excellent performance for high 
quality, active matrix displays, their power requirements, lack 
of bistability and their need for organic thin film transistor back 
planes makes them unnecessarily complex and costly for this 
application. EL also requires the continuous application of 
  
Figure 2. The printed electrochromic display. (a) Scheme of the 
seven layer display stack. (b) Layout of the electrochromic dis-
play showing upper bar display and lower power, hour glass and 
book icons to show operation, activity and reading of test result. 
power to remain illuminated. EC displays, however, undergo a 
(semi)permanent change in their redox characteristics due to the 
application of a potential. Viologens are bypyridyl derivatives 
which undergo a color change upon the application of an appro-
priate reduction potential.10,11 
This change can be rendered bitable, requiring power only to 
switch on the display. This characteristic is particularly useful 
in single use applications such as diagnostic devices, with 
which the test result can be observed many hours or days after 
the test is performed. In this work, an EC display was developed 
using a fully screen-printed seven layer stack (Fig. 2a) onto a 
transparent ITO conductive substrate. First, the passivation 
layer was printed on the ITO substrate, followed by the silver 
conductor, segment electrode and separator as the next layers. 
The last three prints consisted of the common electrode, carbon 
electrode and electrolyte.   
A non-numeric display was selected and designed which 
would indicate the level of the analyte being measured by acti-
vating an appropriate number of display bars (Fig. 2b). This 
semi-quantitative display approach was deemed to be the most 
effective way to allow interpretation by untrained lay users, 
while also greatly simplifying the design of the display driver 
aspect of the circuit. The display was also designed with addi-
tional functions including a power icon to indicate that the de-
vice was switched on and operational, an hour glass icon to in-
dicate that the device was performing an operation and a book 
icon to indicate the reading of the result. Display elements with 
a size of 5 mm (14 point) were employed to facilitate clear and 
comfortable viewing by the user, allowing for a wide range of 
age and ability.12 Display icons were tested for the optimum 
drive voltage, current consumption and time to reach full inten-
sity. It was found that display icons could be driven using a sim-
ple ac drive methodology with a nominal voltage of 1.1 V and 
a current consumption of 25 µA, reaching full intensity after 20 
s. 
Figure 3. The printed battery. (a) Schematic of a two cell battery; 
(b) Photo of the three cell 4.5 Vnom battery. (c) Discharge curve at 
1 mA. 
Printed battery. The printed battery employed in this system 
was primary cell based on zinc/manganese dioxide chemistry, 
designed for one-time (non-rechargeable) use. The nominal 
voltage of this chemical system for a single cell is 1.5 V. These 
batteries can be manufactured by screen printing technology 
and can accommodate a range of operational voltages, currents 
and energy capacities by tailoring the geometries, numbers and 
configurations of cells employed. This battery concept and 
some applications have already been described.13-19 
The battery was developed on a PEN foil substrate. A 
stacked, as opposed to a lateral battery configuration was se-
lected as having greatest energy capacity, while also reducing 
cell footprint. This required electrodes to be printed on top of 
one another, with separators and electrolyte, with each half cell 
printed on a separate substrate, forming a sandwich and further 
sealed within a final PEN layer (Fig. 3a). The energy content of 
this chemical system is dependent on the amount of material 
within the battery cell. Screen printing was used to deposit lay-
ers of the required thickness in the range of 10 to 80 µm to max-
imize energy capacity, while also maintaining a planar config-
uration. 
One of the significant advantages of the screen printing pro-
cess is that a series connection of batteries can be designed and 
easily manufactured. In the current setup, a series connection of 
three single cells was designed to deliver a voltage of 4.5 Vnom 
to drive conventional silicon circuitry (see Device operation) 
(Fig. 3b). The battery requirement for the system was defined 
as >3V with a current flow of 1 mA for up to 600 s. The result-
ing battery was able to supply >3.5 V for 1,000 s at a 1 mA 
discharge rate (Fig. 3c). The blue trace illustrates the typical 
performance of cells manufactured in this way, while the red 
trace illustrates batteries which occasionally fail early. How-
ever, they were still capable of driving the appropriate voltage 
for the duration of the assay. 
Circuit design. The advent of the glucose monitor created a 
new paradigm of a two component system which was composed 
of a disposable printed sensor strip and a separate reusable elec-
tronic instrument incorporating battery, display and operational 
 functions. However, with the advent of low cost, highly inte-
grated silicon electronics using pick and place technology, and 
with rapid advances in organic electronics, the potential now 
exists to fully integrate the electronic circuit instrumentation 
with the rest of the device, giving rise to a new technological 
paradigm. However, silicon circuits must be produced in large 
volumes to achieve cost scaling and silicon costs can be reduced 
by increasing the numbers of devices on a wafer and by reduc-
ing their size and complexity. While there has also been signif-
icant progress in the development of organic circuit electronics, 
the potential for this technology to perform more complex pro-
cessing tasks is still challenging. Thus, with the aim of facilitat-
ing the future integration of both silicon and organic electronics 
into a fully integrated diagnostic platform, a circuit design was 
proposed which was both simple but also fully capable of oper-
ating the proposed diagnostic device. 
The organic circuit was designed with three amplifiers with a 
six-stage voltage converter, connected to the six-bit display el-
ement (Fig. 4a). The difference in resistance of the two electro-
chemical sensors is fed into the amplifiers and subsequently an 
output voltage is obtained. This voltage corresponds to the level 
of H2O2 or cholesterol in the sample based on the determination 
of a calibration slope. The voltage is subsequently fed into the 
voltage converter, which drives respective display elements. 
Table 1 indicates the levels TC and the respective sensor cur-
rents and drive voltages with the corresponding display ele-
ment. 
 
 
Figure 4. a) Block diagram of the organic circuit. Resistance meas-
urements at the test (RT) and control (RC) sensors are amplified in 
a differential logic circuit and subtracted to yield a single amplified 
output voltage from the subtracting circuit. The voltage converter 
then drives the appropriate number of display bars. b) Block dia-
gram of the equivalent silicon circuit. Sensors are driven via a dig-
ital to analogue converter (DAC). Outputs from the Test and Con-
trol sensors are amplified and a peripheral interface controller (PIC) 
performs subtraction and voltage conversion to output to the dis-
play driver. The display driver is composed of a bank of MOSFET 
switches. Display elements were driven at 1.2 V. 
 
Table 1. Relationships between cholesterol concentration, 
sensor currents, resistance ratios and display driver volt-
ages for display illumination. 
Display 
bit 
 Concentration 
(mM) 
Current  
(10-7 A) 
Voltage 
(V) 
RT/RC* 
0  >0 <1.708 -3.19 <1 
1  >2 <1.838 -5.16 <0.535 
2  >4 <2.110 -7.19 <0.361 
3  >5 <2.244 -8.2 <0.311 
4  >6 <2.378 -9.21 <0.273 
5  >7 <2.512 -10.19 <0.244 
*RT/RC: Resistance ratio of test and control electrodes. 
A silicon circuit conforming to this simplified operational prin-
ciple was fabricated using a conventional printed circuit board, 
and a conventional silicon integrated circuit (IC) was developed 
to facilitate testing of the printed sensor, display and battery. 
The integrated printed substrate was connected via a flexible 
parallel connector to the measurement board. The measurement 
circuit utilized a simple potentiostat configuration.20,21 The 
working electrode (WE) of the sensor was kept at the ground 
potential. The potential of the counter electrode (CE) was con-
trolled by an operational amplifier so that the potential of the 
reference electrode (RE) in a steady state very closely follows 
the cell voltage (Vcell). The cell voltage (-100 mV in these meas-
urements) was set by a digital-to-analog converter (DAC). The 
current flowing to the working electrode was converted to volt-
age by the transimpedance amplifier and digitized. A microcon-
troller unit (MCU) controlled the measurement process and out-
put the responses to the printed display. Additional manual 
switching (on/off and measurement timing) were also included. 
Printed electrochemical sensors. Electrochemical sensors 
are particularly suited to integration with organic electronics as 
they are, themselves electrical devices, do not require more 
costly or complex components such as is often the case in opto-
electronics and they can also be easily manufactured in a two-
dimensional, planar configuration using print fabrication. 
For the device demonstrated here, an amperometric sensor 
based on a novel electrocatalytic phenomenon which results in 
the enhanced electrocatalysis of H2O2 at a silver paste, screen 
printed electrode was employed.22 The novel electrocatalytic 
mechanism was based on the formation of liquid crystal lyo-
tropic phases of surfactant which form on the surface of the sil-
ver and bring about an enhancement in the reduction of H2O2 at 
moderate reduction potentials (approx. -100 mV) to avoid inter-
ferences. H2O2 is a very important molecule as it is a by-product 
of many chemical and biochemical reactions and so represents 
an important target for industrial and environmental monitoring 
and diagnostic device development.23-25 Previous work has 
demonstrated that a combination of dodecyl benzenesulfonic 
acid and KCl could bring about an up to 80-fold increase in the 
reduction of H2O2 at silver-paste electrodes. It has also been 
demonstrated that this phenomenon occurred with other combi-
nations of surfactant and salt, including Triton X-100 and 
NaCl.26 and that they could be deposited using inkjet printing.27 
 Recently it was demonstrated that Triton X-100 can also be 
used to effectively solubilize lipoprotein-bound cholesterol and 
cholesterol esters in combination with this enhanced electroca-
talysis to bring about the measurement of total cholesterol 
(TC).28  Here, we further demonstrate the full printed integration 
of a TC sensor with printed display and battery.  
 
Figure 5. (a) Scheme of the electrochemical sensor. The sensor 
comprised a dual working electrode configuration with com-
mon counter and individual reference electrodes. A spacer and 
lid formed a microfluidic sample chamber of approx. 8 µL. The 
working electrodes were composed of screen-printed silver and 
modified with Triton X-100/PBS as catalyst. Total cholesterol 
measurement was achieved with the inkjet-printed deposition of 
cholesterol esterase, cholesterol oxidase and stabilizers. (b) 
Measurement of H2O2 in 0.5% Triton X-100, -0.1 V vs. 
Ag/AgCl, at 420 s. Sensitivity 3.02×10-5 A.mM-1.cm-2 (c) Meas-
urement of total cholesterol in serum. 1.34×10-8 A.mM-1, 
r2=0.99, RSD<10% (n=3). 
The sensor electrodes (silver WE, silver/silver chloride RE 
and silver/carbon CE) were fabricated using screen printing A 
dual electrode configuration was adopted, with one electrode 
providing measurement of background and the other measuring 
the reduction of H2O2 (Fig. 5a). This configuration was chosen 
to reduce the complexity of the circuit electronics and the cali-
bration required in compensating for local device and environ-
mental variations. Following inkjet printing of electrocatalyst 
and assay reagents, the sensor was encapsulated to form a thin 
layer microfluidic sample chamber requiring a sample volume 
of approx. 8 µL, to make it applicable to fingerstick blood draw 
measurements.29 
The measurement of H2O2 using electrodes modified with the 
inkjet-printed Triton X-100 (0.5% v/v) in PBS is shown in Fig. 
5b. The fully printed sensor was tested for the measurement of 
H2O2 in the range of 0 to 5 mM. Catalysis was significantly en-
hanced in the presence of Triton X-100, while in its absence, 
little catalysis was observed, being 1.2×10-5 A at 5 mM H2O2, 
in Triton (3.02×10-5 A.mM-1.cm-2), compared with 5.91×10-7 A 
in PBS alone; some 20-fold enhancement. This was comparable 
to the sensitivity of 4.9×10-5 A.mM-1.cm-2 previously achieved 
using inkjet-printed DBSA/KCl.27 Recently, H2O2 sensors based 
on inkjet-printed Prussian blue nanoparticles have achieved 
sensitivities of 7.62×10-5 A.mM-1.cm-2.30   
For the measurement of TC, both ChEs and ChOx were de-
posited using inkjet printing, along with Triton X-100, and en-
zyme stabilizers. Measurement of cholesteryl ester in the range 
of 0 to 9 mM was selected to demonstrate direct (undiluted) 
measurement of cholesterol in the clinically relevant range.30,31 
The majority of cholesterol is transported by lipoproteins in the 
form of cholesteryl esters. These can be transformed to choles-
terol by ChEs and to cholest-4-en-3-one and H2O2 by ChOx. 
Triton X-100 between 0.2 and 0.5% has been shown to be opti-
mal for full release of cholesterol esters from both HDL and 
LDL, which is a pre-requisite for TC measurement. Other com-
binations of surfactant and protecting agents have been shown 
to result in selectivity to either LDL-C or HDL-C.28  
The measurement of TC in the fully printed sensor device 
demonstrated good linearity in the range from 0 to 9 mM with 
a slope of 1.34×10-8 A.mM-1, r2=0.99, RSD<10% (n=3) (Fig. 
5c). Replicate measurements were made with different sensors 
with the same stock of TC standard. Levels of TC below 5.2 
mM are considered desirable and of low risk while 5.2 to 6.2 
mM is considered borderline high risk. Values greater than 6.2 
mM are considered high risk. This was reflected in display col-
our coding of green (0 to 4 mM), yellow (4 to 5 mM), orange (5 
to 6 mM), light red (6 to 7 mM) and dark red (>7 mM). The 
resulting sensor was capable of measuring TC from 0 to 9 mM 
at moderate (-100 mV) potentials to minimize potential redox 
interferences. The presence of surfactant may also assist in re-
ducing interference due to biofouling. The generation of sub-
microampere currents, resulting in nW levels of power con-
sumption is an important feature in minimizing power require-
ments (battery size). 
Fabrication integration. Organic and printed electronics 
presents an exciting, but also a challenging opportunity to mass 
manufacture novel and advanced devices. The physical integra-
tion of multiple functionalities creates an exponential complex-
ity problem due to the numbers of different functional materials, 
their particular process requirements and their compatibility 
with other materials and other processes. As a result, achieving 
true integration of such heterogeneous devices has remained 
challenging. Various approaches have been taken to address 
this problem. Some have used multiple substrates on which to 
fabricate various system elements33, while others have used pre-
fabricated sub-components such as separate sensor strips and 
 battery components to achieve instrument-free glucose meas-
urement.33 However, the approach taken here was to demon-
strate integration of heterogeneous subsystems on a single sub-
strate, for which all processes must be made fully inter-compat-
ible at the process level. Several integration principles were ap-
plied here to achieve integration. Redundancy was removed 
from the various components, where possible. Processes were 
also sequenced to ensure that materials with least sensitivity, or 
more rigorous process requirements were performed prior to 
those with greater sensitivity. The design layout was also opti-
mized to eliminate any potential impact of one subsystem on 
another. The integrated printed sensor, battery and display is il-
lustrated in Fig. 6. As the display is printed ‘face down’ to the 
substrate and the sensor is fabricated ‘face up’ from the sub-
strate, a simple microfluidic was incorporated to allow sample 
application on the same side as the display. Sensor and display 
were fabricated together on a single substrate and the battery 
was prepared on a separate substrate and subsequently inte-
grated onto the common substrate. Final addition of sensor 
modification layers was then performed via inkjet printing, re-
sulting in a layer stack of 22 processing steps. Although only 24 
fully integrated devices were fabricated, operational yields of 
100% were achieved by having good design tolerances in all 
print process steps.  
Device operation. The integrated prototype device is shown 
in Fig. 7a. The device was activated by operating a manual 
on/off touch switch which activates the circuit and illuminates 
the power on icon. The sample chamber was composed of a hy-
drophilic polymer bonded with a PSA. Filling was by capillary 
action, with air escape through two vias in the lid of the sample 
chamber. Upon addition of sample (8 µL of H2O2 or cholesterol 
in serum), the second switch is activated to begin the measure-
ment timing of the device. A potential of -100 mV is applied to 
the sensor working electrodes of both the control and test cells. 
For measurement of TC, the assay employed a 400 s incubation 
between cholesterol and cholesterol oxidase to allow full con-
version to cholest-4-en-3-one and hydrogen peroxide. During 
this period, the hour glass icon is illuminated. After 400 s, the 
difference in current between the two sensors is subtracted and 
applied to the stored calibration constant of the device and illu-
minates the appropriate number of display bars. 
 
Figure 6. Integrated printed system components. Sensor (bottom 
right), display (bottom left) and battery (top) were effectively inte-
grated onto a single substrate using a combination of screen print-
ing, inkjet printing, bonding and lamination processes into a mon-
olithic 22 layer stack. 
Fig. 7b shows the test set up of separate display and sensor to 
allow reuse of the displays during laboratory testing. To the 
right of Fig. 7b shows the illumination of one display bar for 1 
mM H2O2, three bars for 3 mM and five bars for 5 mM. In ad-
dition, the ‘book’ icon is displayed indicating that it is time for 
the device reading. A video of the operation of the device can 
be viewed in Supporting Information. 
 
Figure 7. Operation of the integrated sensor system. (a) The assem-
bled prototype showing printed cover with QR code, cholesterol 
concentration values and sample application zone. Below is the 
electronic control board. (b) Testing of the device using separate 
displays and sensors (displays could be reused during laboratory 
testing). On the right shows the results of the addition of 1, 3 and 5 
mM H2O2, resulting in the activation of an equivalent number of 
display blocks. 
Communications interface. As well as being readable visu-
ally, a communications interface was also developed in associ-
ation with the device which allows remote transmission of the 
test result via a mobile phone (Fig. 8). This interface was sup-
ported with additional printed features around the display (Fig. 
7a). These include a color-coded bar to indicate to the user 
 whether the measured level of analyte (in this instance choles-
terol) was normal or too high. In addition, the device was de-
signed with QR coding. This coding contains specific device 
identification that can be used in several ways including device 
authentication, supply chain management and quality control 
monitoring.32   
In addition, the QR also allows the location and orientation 
of the display to be detected. Result detection and interpretation 
is performed using an Android smartphone application. The 
‘app’ is designed to provide patient identification and authenti-
cation. The app employed the phone’s camera to take a picture 
of the display. Using the QR code, the app identifies the device, 
locates the device display, detects the location and number of 
display blocks activated, and can record the date, time and lo-
cation of the test. A picture of the display, along with test result 
and associated metadata can be automatically sent via SMS to 
a remote, healthcare management site to monitor health status, 
treatment efficacy and testing compliance. The issue as to 
whether or not the test result should be interpreted locally by 
the phone has implications for the type of medical device regu-
latory approval required of the mobile phone. Operation of the 
mobile phone communications app can be seen in the accompa-
nying video (Supporting Information). 
 
 
Figure 8. The communications interface mobile phone application. 
The app allows an image of the SIMS device to be captured by the 
phone’s camera. Image processing algorithms automatically locate 
the chip and the QR features. The reading on the chip is automati-
cally recorded (small grey squares) and the QR codes are used to 
identify the test and track the results. 
Cholesterol testing is currently used to manage hypercholes-
terolemia which is a major risk factor in atherosclerosis. Treat-
ment is typically by way of lifestyle management (diet and ex-
ercise), as well as administration of statins. Point of care devices 
employing strips and meters are available and strips typically 
retail for between US$2 and US$3 per strip. This requires the 
more challenging acceptance and integration of such technol-
ogy into the lifestyle of often elderly patients. Pharmacy-based 
testing is also available at over US$12 per test. The prototype 
production cost of the SIMS device was approximately US$5, 
which could be significantly reduced during production scale 
up and mass manufacture to approximately US$1.50 or less, 
with a target sale price of US$5. It also offers users greater sim-
plicity of self-testing, as well as connectivity with health care 
providers. Current test time is approximately seven minutes 
which has the potential to be reduced to less than two or three 
minutes and which would be acceptable to most users. While 
the measurement of TC has been demonstrated here, the addi-
tion of a sensor for the measurement of high density lipoprotein 
cholesterol (HDL-C) would facilitate subtractive measurement 
of non-HDL-C (low density lipoprotein or LDL and very low 
density lipoprotein or VLDL cholesterol) using the Friedwald 
equation.35 Non-HDL-C is considered to be atherogenic and so 
is better than the separate measurement of LDL-C.36 
CONCLUSIONS 
Printed electronics was successfully used to achieve the fabri-
cation of a sensor, display and battery into a fully integrated 
diagnostic device. The sensors were shown to be capable of the 
quantitative measurement of H2O2 and total cholesterol, while 
the display, battery and circuit all demonstrated component 
functionality. The final integrated device was also able to 
demonstrate the measurement of H2O2. The device was also ca-
pable of remote result transmission via mobile phone. Such a 
device could form the basis of a new approach to diagnostic de-
vice fabrication and enhance the management of disorders such 
as hypercholesterolemia. 
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